Article in International journal of dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Diana Estefania Ramos PeñaDepartment of Stomatology, School of Dentistry, University of São Paulo, São Paulo, SP, Brazil, usp.br.ORCID https://orcid.org/0000-0003-4880-4780
Oulfa Boussetta-CharfiDepartment of Infectious Agents and Hygiene, University-Hospital of Saint-Etienne, Saint-Etienne, France, chu-st-etienne.fr.ORCID https://orcid.org/0009-0000-6544-2078
Angéline AntezackMicrobes, Evolution, Phylogeny and Infection (MEPHI), IHU-Méditerranée Infection, Marseille, France, mediterranee-infection.com.ORCID https://orcid.org/0000-0002-4424-1573
Nacera AmrouneMicrobes, Evolution, Phylogeny and Infection (MEPHI), IHU-Méditerranée Infection, Marseille, France, mediterranee-infection.com.
Philippe ColsonUR MEPHI (Research Unit D-258, Microbes Evolution Phylogeny and Infection), Aix Marseille University/Laboratory of Infectious Agents, Timone Hospital, Assistance Publique-Hôpitaux de Marseille/IHU (Institut Hospitalo Universitaire) -Méditerranée Infection, Marseille, France, ap-hm.fr.ORCID https://orcid.org/0000-0001-6285-0308
Virginie Monnet-CortiMicrobes, Evolution, Phylogeny and Infection (MEPHI), IHU-Méditerranée Infection, Marseille, France, mediterranee-infection.com.ORCID https://orcid.org/0000-0002-3642-6981
Rafael Simone SaiaLaboratory of Intestinal Pathophysiology, Department of Physiology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil, usp.br.ORCID https://orcid.org/0000-0002-9771-7627
Johann GuillemotTeam Mucosal Immunity and Pathogen Agents (GIMAP), International Centre of Research in Infectiology (CIRI), INSERM U1111, Ecole Nationale Supérieure de Lyon, University of Lyon, University of Saint-Etienne, Saint-Etienne, France, universite-lyon.fr.ORCID https://orcid.org/0000-0002-5902-9188
Bruno PozzettoTeam Mucosal Immunity and Pathogen Agents (GIMAP), International Centre of Research in Infectiology (CIRI), INSERM U1111, Ecole Nationale Supérieure de Lyon, University of Lyon, University of Saint-Etienne, Saint-Etienne, France, universite-lyon.fr.ORCID https://orcid.org/0000-0002-2603-8467
Sylvie PilletTeam Mucosal Immunity and Pathogen Agents (GIMAP), International Centre of Research in Infectiology (CIRI), INSERM U1111, Ecole Nationale Supérieure de Lyon, University of Lyon, University of Saint-Etienne, Saint-Etienne, France, universite-lyon.fr.ORCID https://orcid.org/0000-0002-0882-3162
Bernard La ScolaUR MEPHI (Research Unit D-258, Microbes Evolution Phylogeny and Infection), Aix Marseille University/Laboratory of Infectious Agents, Timone Hospital, Assistance Publique-Hôpitaux de Marseille/IHU (Institut Hospitalo Universitaire) -Méditerranée Infection, Marseille, France, ap-hm.fr.ORCID https://orcid.org/0000-0001-8006-7704
Thomas BourletTeam Mucosal Immunity and Pathogen Agents (GIMAP), International Centre of Research in Infectiology (CIRI), INSERM U1111, Ecole Nationale Supérieure de Lyon, University of Lyon, University of Saint-Etienne, Saint-Etienne, France, universite-lyon.fr.ORCID https://orcid.org/0000-0002-9226-1149
Ana Carolina Fragoso MottaDepartment of Stomatology, Public Health and Forensic Dentistry, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil, usp.br.ORCID https://orcid.org/0000-0002-3887-9239
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
People living with HIV (PLWH) in combined antiretroviral therapy (cART) face microbiota shifts linked to immune status, ART regimen, and periodontal diseases, which are capable of inducing local and systemic inflammation. This study aimed to analyze the oral microbial community composition in PLWH under cART with (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Interplay Between Oral Microbiota and Mouth Health in People Living With HIV Under Antiretroviral Therapy With or Without Periodontitis. · full record | OpenQuestion